Skip to search boxSkip to navigationSkip to main content

Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky

  • Robert M. Ore(corresponding author)
    ,
  • Quan Chen
    ,
  • Christopher P. Desimone
    ,
  • Rachel W. Miller
    ,
  • Lauren A. Baldwin
    ,
  • John R. Van Nagell
*Corresponding author for this work
  • University of Kentucky
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Objectives Adherence to National Comprehensive Cancer Network (NCCN) guidelines for ovarian cancer treatment improves patient outcomes. The aim of this study was to assess disparities associated with ovarian cancer treatment in the state of Kentucky and central Appalachia. Methods Data on patients diagnosed as having ovarian cancer from 2007 through 2011 were extracted from administrative claims-linked Kentucky Cancer Registry data. NCCN compliance was defined by stage, grade, surgical procedure, and chemotherapy. Selection criteria were reviewed carefully to ensure data quality and accuracy. Descriptive analysis, logistic regression, and Cox regression analyses were performed to examine factors associated with guidelines compliance and survival. Results Most women were aged 65 years or older (62.5%) and had high-grade (65.9%) and advanced-stage (61.0%) ovarian cancer. Two-thirds of cases (65.9%) received NCCN-recommended treatment for ovarian cancer. The hazard ratio of death for women who did not receive NCCN-compliant care was 62% higher compared with the women who did receive NCCN-compliant treatment. Results from the logistic regression showed that NCCN-compliant treatment was more likely for women aged 65 to 74 years compared with women aged 20 to 49 years, late-stage compared with early-stage cancers, receipt of care at tertiary care hospitals, and privately insured compared with Medicaid or Medicare. Conclusions When the treatment of ovarian cancer did not follow NCCN recommendations, patients had a significantly higher risk of death. Women were less likely to receive NCCN-compliant care if they were younger (20-49 years), had early-stage disease, did not have private insurance, or had care provided at a nontertiary care hospital.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 333-341 (9 pages)

Journal (Volume, Issue Number)

Southern medical journal (Volume 111, Issue 6)

Publication milestones

  • Published - 06/01/2018

Publication status

Published - 06/01/2018

ISSN

0038-4348

Publication IDs

  • Scopus: 85048013025
  • PubMed: 29863220

Publication metrics

Metrics

Fractional count
1
Fractional count
0.09
Fractional count
10
Fractional count
0.91
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
5
Captures
14
Social media
190

Funding Details

From the Department of Obstetrics and Gynecology, and Biostatistics and Bioin-formatics Shared Resource Facility, Division of Gynecologic Oncology, Markey Cancer Center, the Departments of Biostatistics and Epidemiology, College of Public Health, University of Kentucky, Lexington. Correspondence to Dr Robert M. Ore, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Markey Cancer Center, University of Kentucky, Lexington, KY, 40536. E-mail: [email protected]. To purchase a single copy of this article, visit sma.org/smj-home. To purchase larger reprint quantities, please contact [email protected]. B.H. has received compensation from National Institutes of Health/National Cancer Institute grant no. P30 CA177558. The remaining authors did not report any financial relationships or conflicts of interest. Accepted January 9, 2018. Copyright © 2018 by The Southern Medical Association 0038-4348/0–2000/111-333 DOI: 10.14423/SMJ.0000000000000821
FundersFunding number
NIH
-
NCI
P30CA177558